Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples